SEC Form 4 · accession 0001144204-18-062708

Cimarex Resolute LLC · REN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Exec. VP, Gen Counsel & Secy

Period of report

Nov 28, 2018

Accepted (ET)

Nov 30, 2018 · 6:18 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001469510

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F2,F3	Nov 28, 2018	M	14,876	$6.75	A	134,140	D
Common Stock^F2,F3	Nov 28, 2018	M	19,573	$2.915	A	153,713	D
Common Stock^F1,F2,F3	Nov 28, 2018	F	4,527	$34.79	D	149,186	D
Common Stock^F2,F3	Nov 30, 2018	S	29,922	$34.791	D	119,264	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to buy)^F4	$6.75	Nov 28, 2018	M	14,876	D	—	May 5, 2025	Common Stock	14,876	0	D
Employee Stock Option (Right to buy)^F5	$2.915	Nov 28, 2018	M	19,573	D	—	Feb 18, 2026	Common Stock	19,573	0	D

F1Represents shares surrendered to Issuer to cover the exercise price of the option, as permitted pursuant to Issuer's 2009 Performance Incentive Plan, upon the exercise of 34,449 stock options.
F2Includes 68,728 shares of restricted stock subject to Time- and Performance- Vesting criteria, which vest in annual installments in accordance with such criteria through March 8, 2021.
F3Includes 11,000 shares held by the Reporting Person in an IRA account.
F4Includes 4,959, 4,959 and 4,958 options, which became exercisable on 5/5/2016, 5/5/2017 and 5/5/2018, respectively.
F5Includes 9,787 and 9,786 options, which became exercisable on 3/8/2017 and 3/8/2018, respectively.

Note: Option exercises and sales completed for year-end tax planning purposes.